本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nurix Therapeutics

22.16
-0.1900-0.85%
盘前:22.510.3500+1.58%05:09 EDT
成交量:285.24万
成交额:6,333.25万
市值:22.91亿
市盈率:-6.50
高:22.58
开:22.27
低:22.03
收:22.35
52周最高:28.23
52周最低:9.14
股本:1.03亿
流通股本:7,411.19万
量比:1.86
换手率:3.85%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
净资产收益率:-80.30%
总资产收益率:-40.06%
市净率:5.69
市盈率(LYR):-7.26

数据加载中...

2026/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/23

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/10

重要事件披露

Form 8-K - Current report
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report